CurePSP New Investigator Award
The CurePSP New Investigator Award funds early career researchers for innovative pilot studies on the biology and mechanisms of PSP and CBD.
Funder: CurePSP
Due Dates: October 15, 2026 (Full proposal submission deadline, 5:00 PM ET)
Funding Amounts: Up to $100,000 for one- or two-year projects; direct costs only, no indirects.
Summary: Seed funding for early career researchers to conduct innovative pilot studies on progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).
Description
The CurePSP New Investigator Award provides essential seed funding to early career investigators pursuing research on progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). The program aims to support innovative pilot or proof-of-concept studies in fundamental neurobiology, molecular and cellular mechanisms, or translational research that can generate foundational data for future, larger-scale projects. The award is intended to help researchers advance the understanding of PSP and CBD and accelerate the development of new therapeutics and biomarkers. Both U.S. and international applicants are eligible, provided they meet the early career criteria.
